NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

子宮肌瘤治療的全球市場:2019年∼2026年

Global Uterine Fibroids Treatment Market - 2019-2026

出版商 DataM Intelligence 商品編碼 968940
出版日期 內容資訊 英文 218 Pages
商品交期: 最快1-2個工作天內
價格
子宮肌瘤治療的全球市場:2019年∼2026年 Global Uterine Fibroids Treatment Market - 2019-2026
出版日期: 2020年09月30日內容資訊: 英文 218 Pages
簡介

全球子宮肌瘤治療市場具有巨大的成長機會。該市場主要由女性老年人口增加,荷爾蒙疾病患病率增加和生活方式改變引起的患者人數增加所驅動。子宮肌瘤是女性子宮中最常見的良性,非癌性腫瘤,最常見於生育年齡。只有在肌瘤引起症狀和治療選擇範圍從藥物到侵入性手術的情況下,才進行治療。。

本報告提供全球子宮肌瘤治療市場調查,主要的趨勢,產業分析,各治療法,各類型,各地區的分析,競爭情形,企業簡介等資訊。

目錄

第1章 調查手法和範圍

第2章 市場趨勢

第3章 產業分析

  • 成長促進因素
  • 阻礙因素
  • 威脅和機會
  • 波特的五力分析

第4章 市場分析

  • 各治療法
    • 荷爾蒙療法
    • 促性腺激素分泌放出荷爾蒙受體激動劑(GnRH受體激動劑)
    • 子宮動脈栓塞術
    • 子宮肌瘤切除術
    • 子宮切除術
  • 各類型
    • 粘膜下
    • 漿膜下
    • 牆內
    • 有莖性
    • 血栓
    • ulipristal acetate

第5章 地區市場分析

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 其他
  • 南美
    • 巴西
    • 阿根廷
    • 其他
  • 其他地區

第6章 競爭情形

  • 市場佔有率分析
  • 合併和收購分析
  • 新產品的銷售

第7章 企業簡介

  • Allergan
  • Gedeon Richter
  • Repros
  • Bayer HealthCare
  • AbbVie
  • Movant
  • ObsEva

第8章 附錄

目錄

Market Overview

Global Uterine Fibroids Treatment Market Expected to reach a high CAGR by 2027: DataM Intelligence

Uterine Fibroids are the most common benign, non-cancerous tumors of a woman's uterus, most often seen during the childbearing years.

Fibroids are only treated if they cause symptoms and treatment options to range from medications to invasive surgery.

Market Growth

The global Uterine Fibroids Treatment market has significant opportunities to grow.

The market is primarily driven by increasing patient pool owing to increasing female geriatric population, growing prevalence of hormonal disorders and changing lifestyle.

Around 700,000 women in seven major market countries have symptoms severe enough to require surgery or radical treatment.

Market Restraints

However, high R&D cost is likely to hinder market growth.

Market Segmentation

The global Uterine Fibroids Treatment market report segments the market by type, by treatment type, and by region.

Based on the type of fibroid, the market comprises Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and Pedunculated.

Of these, intramural fibroids hold the most significant market share.

Based on treatment type, the market is categorized into hormone therapy, gonadotropin-releasing hormone agonists, uterine artery embolization, myomectomy, and hysterectomy. Drug therapy is an option for some women with fibroids.

Treatment options for traditional surgical procedures include abdominal myomectomy and hysterectomy. Other non-standard but new treatments available for uterine fibroids include Radiofrequency ablation and Anti-hormonal drugs.

Geographical Analysis

Geographically, the market is segmented into five major regions, namely North America, South America, Europe, Asia Pacific, and RoW.

North America dominates the market for Uterine Fibroids Treatment owing to millions of women in the US having fibroids.

National Uterine Fibroids Foundation estimates that as many as 80% of all women in the US have uterine fibroids, and one in four of these women have symptoms severe enough to require treatment.

Key Players

The report profiles the following companies in Uterine Fibroids Treatment market - Allergan, Gedeon Richter, Repros, Bayer HealthCare, AbbVie, Movant, ObsEva and so on.

Key Points Covered in the Report

By Treatment Type

Hormone therapy

Gonadotropin-releasing hormone agonists

Uterine artery embolization

Myomectomy

Hysterectomy

By Type

Submucosal

Subserosal

Intramural

blood clots

Pedunculated

ulipristal acetate

By Region

Asia Pacific (China, Japan, India, Australia, Rest of Asia Pacific)

Europe (Germany, France, The UK, Italy, Spain, Rest of Europe)

North America (The USA, Canada, Mexico)

South America (Brazil, Argentina, Rest of South America)

Rest of the World

Why purchase the report?

Visualize the composition of Uterine Fibroids Treatment market across each indication, regarding type and treatment options, highlighting the critical commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of the market - level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for crucial Uterine Fibroids Treatments of all major market players

Target Audience

Equipment Suppliers/ Buyers

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Table of Contents

1. Uterine Fibroids Treatment Market - Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Scope of the Report

2. Uterine Fibroids Treatment Market Trends

  • 2.1. Key Trends & Developments

3. Uterine Fibroids Treatment Industry Analysis

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Threats and Opportunities
  • 3.4. Porter's 5 Forces

4. Uterine Fibroids Treatment Market Segmentation Analysis

  • 4.1. By Treatment Type
    • 4.1.1. Hormone therapy
      • 4.1.1.1. Oral contraceptives and progestins
      • 4.1.1.2. Androgens
    • 4.1.2. Gonadotropin-releasing hormone agonists (GnRH agonists)
    • 4.1.3. Uterine artery embolization
    • 4.1.4. Myomectomy
    • 4.1.5. Hysterectomy
  • 4.2. By Type
    • 4.2.1. Submucosal
    • 4.2.2. Subserosal
    • 4.2.3. Intramural
    • 4.2.4. Pedunculated
    • 4.2.5. blood clots
    • 4.2.6. ulipristal acetate

5. Uterine Fibroids Treatment Market - Geographical Analysis

  • 5.1. North America
    • 5.1.1. The USA
    • 5.1.2. Canada
    • 5.1.3. Mexico
  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. The UK
    • 5.2.4. Italy
    • 5.2.5. Spain
    • 5.2.6. Rest of Europe
  • 5.3. Asia Pacific
    • 5.3.1. China
    • 5.3.2. Japan
    • 5.3.3. India
    • 5.3.4. Australia
    • 5.3.5. Rest of Asia Pacific
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
    • 5.4.3. Rest of South America
  • 5.5. Rest of the World

6. Uterine Fibroids Treatment Market - Competitive Landscape

  • 6.1. Market Share Analysis
  • 6.2. Mergers and Acquisitions Analysis
  • 6.3. New Product Launches

7. Uterine Fibroids Treatment Market - Company Profiles

  • 7.1. Allergan
  • 7.2. Gedeon Richter
  • 7.3. Repros
  • 7.4. Bayer HealthCare
  • 7.5. AbbVie
  • 7.6. Movant
  • 7.7. ObsEva

8. Uterine Fibroids Treatment Market - Appendix

  • 8.1. Sources
  • 8.2. List of Tables
  • 8.3. Expert Panel Validation
  • 8.4. Disclaimer
  • 8.5. Contact Us